Fisher Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Fisher Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-545,198	Closed	-$425K	–	994
2022 Q2	$425K	Hold	545,198	–	–	﹤0.01%	743
2022 Q1	$703K	Hold	545,198	–	–	﹤0.01%	670
2021 Q4	$692K	Buy	545,198 +487,323	+842%	+$871K	﹤0.01%	698
2021 Q3	$126K	Sell	57,875 -275	-0.5%	-$751	﹤0.01%	893
2021 Q2	$218K	Buy	58,150 +300	+0.5%	+$1.04K	﹤0.01%	866
2021 Q1	$189K	Hold	57,850	–	–	﹤0.01%	866
2020 Q4	$197K	Hold	57,850	–	–	﹤0.01%	882
2020 Q3	$236K	Sell	57,850 -28,104	-33%	-$107K	﹤0.01%	784
2020 Q2	$291K	Sell	85,954 -45,050	-34%	-$131K	﹤0.01%	726
2020 Q1	$305K	Hold	131,004	–	–	﹤0.01%	682
2019 Q4	$477K	Sell	131,004 -70,260	-35%	-$568K	﹤0.01%	668
2019 Q3	$1.67M	Hold	201,264	–	–	﹤0.01%	563
2019 Q2	$1.73M	Buy	201,264 +20,601	+11%	+$184K	﹤0.01%	558
2019 Q1	$1.93M	Hold	180,663	–	–	﹤0.01%	526
2018 Q4	$1.58M	Hold	180,663	–	–	﹤0.01%	555
2018 Q3	$3.04M	Buy	180,663 +27,962	+18%	+$605K	﹤0.01%	478
2018 Q2	$3.2M	Sell	152,701 -45,994	-23%	-$852K	﹤0.01%	488
2018 Q1	$3.2M	Sell	198,695 -1,557	-0.8%	-$30.8K	﹤0.01%	476
2017 Q4	$3.79M	Buy	200,252 +21,043	+12%	+$381K	0.01%	453
2017 Q3	$2.52M	Buy	+179,209	New	+$1.62M	﹤0.01%	477

Other funds holding SPPI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management's SPPI Position: Q3 2022 in Review

Fisher Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 545,198 shares — an estimated $425K sold.

Fisher Asset Management first reported a position in SPPI in Q3 2017 and held it in 20 quarters. The position peaked at $3.79M in Q4 2017. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

Fisher Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
Fisher Asset Management sold 545,198 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $425K.
Fisher Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and held it in 20 quarters.
Fisher Asset Management's Spectrum Pharmaceuticals Inc position peaked at $3.79M in Q4 2017.
75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on Fisher Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.